Transcatheter aortic valve replacement: Current status and future directions

Chintan S. Desai; Eric E. Roselli; Lars G. Svensson; Robert O Bonow

doi:10.1053/j.semtcvs.2013.09.002

Transcatheter aortic valve replacement: Current status and future directions

Chintan S. Desai, Eric E. Roselli, Lars G. Svensson, Robert O Bonow^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Transcatheter aortic valve replacement (TAVR) is a revolutionary therapy for patients with aortic stenosis. Large registries and randomized controlled trials have demonstrated that TAVR is safe and effective in patients considered inoperable because of severe comorbidities and those who are high-risk surgical candidates. As TAVR evolves for lower-risk patients, attention will need to focus on reducing the rates of vascular injury, stroke, and paravalvular regurgitation. In this review, we discuss the status of TAVR in clinical practice, including patient selection, preoperative evaluation, techniques, and complications.

Original language	English (US)
Pages (from-to)	193-196
Number of pages	4
Journal	Seminars in Thoracic and Cardiovascular Surgery
Volume	25
Issue number	3
DOIs	https://doi.org/10.1053/j.semtcvs.2013.09.002
State	Published - Dec 16 2013

Keywords

Aortic stenosis
Aortic valve replacement
Transcatheter aortic valve replacement

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.semtcvs.2013.09.002

Cite this

@article{031c0ff0bbb9443090c8b60f1b7954b4,

title = "Transcatheter aortic valve replacement: Current status and future directions",

abstract = "Transcatheter aortic valve replacement (TAVR) is a revolutionary therapy for patients with aortic stenosis. Large registries and randomized controlled trials have demonstrated that TAVR is safe and effective in patients considered inoperable because of severe comorbidities and those who are high-risk surgical candidates. As TAVR evolves for lower-risk patients, attention will need to focus on reducing the rates of vascular injury, stroke, and paravalvular regurgitation. In this review, we discuss the status of TAVR in clinical practice, including patient selection, preoperative evaluation, techniques, and complications.",

keywords = "Aortic stenosis, Aortic valve replacement, Transcatheter aortic valve replacement",

author = "Desai, {Chintan S.} and Roselli, {Eric E.} and Svensson, {Lars G.} and Bonow, {Robert O}",

year = "2013",

month = dec,

day = "16",

doi = "10.1053/j.semtcvs.2013.09.002",

language = "English (US)",

volume = "25",

pages = "193--196",

journal = "Seminars in Thoracic and Cardiovascular Surgery",

issn = "1043-0679",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Transcatheter aortic valve replacement

T2 - Current status and future directions

AU - Desai, Chintan S.

AU - Roselli, Eric E.

AU - Svensson, Lars G.

AU - Bonow, Robert O

PY - 2013/12/16

Y1 - 2013/12/16

N2 - Transcatheter aortic valve replacement (TAVR) is a revolutionary therapy for patients with aortic stenosis. Large registries and randomized controlled trials have demonstrated that TAVR is safe and effective in patients considered inoperable because of severe comorbidities and those who are high-risk surgical candidates. As TAVR evolves for lower-risk patients, attention will need to focus on reducing the rates of vascular injury, stroke, and paravalvular regurgitation. In this review, we discuss the status of TAVR in clinical practice, including patient selection, preoperative evaluation, techniques, and complications.

AB - Transcatheter aortic valve replacement (TAVR) is a revolutionary therapy for patients with aortic stenosis. Large registries and randomized controlled trials have demonstrated that TAVR is safe and effective in patients considered inoperable because of severe comorbidities and those who are high-risk surgical candidates. As TAVR evolves for lower-risk patients, attention will need to focus on reducing the rates of vascular injury, stroke, and paravalvular regurgitation. In this review, we discuss the status of TAVR in clinical practice, including patient selection, preoperative evaluation, techniques, and complications.

KW - Aortic stenosis

KW - Aortic valve replacement

KW - Transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=84890090350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890090350&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2013.09.002

DO - 10.1053/j.semtcvs.2013.09.002

M3 - Article

C2 - 24331140

AN - SCOPUS:84890090350

SN - 1043-0679

VL - 25

SP - 193

EP - 196

JO - Seminars in Thoracic and Cardiovascular Surgery

JF - Seminars in Thoracic and Cardiovascular Surgery

IS - 3

ER -

Transcatheter aortic valve replacement: Current status and future directions

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this